Pura Vida Investments’s Apollo Endosurgery, Inc. APEN Stock Holding History

Pura Vida Investments’s Portfolio APEN Stock Details APEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-427,057	Closed	-$2.35M	–	265
2022 Q3	$2.35M	Hold	427,057	–	–	0.14%	125
2022 Q2	$1.56M	Hold	427,057	–	–	0.09%	150
2022 Q1	$2.58M	Buy	427,057 +52,400	+14%	+$319K	0.08%	151
2021 Q4	$3.16M	Buy	+374,657	New	+$3.27M	0.11%	133

Other funds holding APEN

CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return

ACM

Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Pura Vida Investments's APEN Position: Q4 2022 in Review

Pura Vida Investments sold out of Apollo Endosurgery, Inc. (APEN) in Q4 2022, closing a stake of 427,057 shares — an estimated $2.35M sold.

Pura Vida Investments first reported a position in APEN in Q4 2021 and held it in 4 quarters. The position peaked at $3.16M in Q4 2021. 81 funds tracked by Wall St. Rank hold APEN as of Q4 2022.

Pura Vida Investments reported no remaining Apollo Endosurgery, Inc. position as of Q4 2022 after selling out during the quarter.
Pura Vida Investments sold 427,057 Apollo Endosurgery, Inc. shares in Q4 2022, an estimated $2.35M.
Pura Vida Investments first reported a position in Apollo Endosurgery, Inc. in Q4 2021 and held it in 4 quarters.
Pura Vida Investments's Apollo Endosurgery, Inc. position peaked at $3.16M in Q4 2021.
81 funds tracked by Wall St. Rank held Apollo Endosurgery, Inc. as of Q4 2022.

Based on Pura Vida Investments's 13F filing for Q4 2022, filed 14 Feb 2023.